High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil

Journal of Medical Virology

Volumn 81, Issue 7, 2009, Pages 1270-1275

  Paesi, Suelen ^a   Serafini, Eduardo Pretto ^a   Barea, Fernanda ^a   Madi, Sonia Regina Cabral ^a   Echeverrigaray, Sergio ^a  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Cancer; Cervical; Genotype 58; HPV; Human papillomavirus; PCR

Indexed keywords

VIRUS DNA;

ARTICLE; BRAZIL; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SOCIOECONOMICS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; ADOLESCENT; ADULT; AGED; CLASSIFICATION; CYTOLOGY; DNA FINGERPRINTING; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; UTERINE CERVIX; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 58;

ADOLESCENT; ADULT; AGED; BRAZIL; CERVIX UTERI; DNA FINGERPRINTING; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 67649957965     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21410     Document Type: Article

References (46)

1. Ault KA. 2007. Human papillomavirus vaccines and the potential for cross-protection between related HPV types. Gynecol Oncol 107: S3-S31. (Pubitemid 47552539)
2. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingod A, Manos MM. 1991. Genital human papillomavirus infection in female university students as determined by a PCRbased method. JAMA 265:472-477.
3. Bernard H. 2005. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Microbiol 32:1-6.
4. Bernard H-U, Chan S-Y, Manos MM, Ong C-K, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. 1994. Identification and assessment of known and novel human papillomavirus by poly merase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170:1077-1085. (Pubitemid 24328606)
5. BethesdaW. 1988. The Bethesda systemfor reporting cervical/vaginal cytological diagnosis. JAMA 262:931-934.
6. Bosch X, Manos MM, Muñ oz N, Sherman M, Jansen AM, Peto J, Schiffman HM, Moreno V, Kurman R, Shah VK, International Biological Study on Cervical Cancer (IBSCC) Study Group. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 87:796-802.
7. Camara GNL, Cerqueira DM, Oliveira APG, Silva EO, Carvalho LGS, Martins CRF. 2003. Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 98:879-883. (Pubitemid 38019535)
8. Cavalcanti SMB, Frugulhetti ICP, Passos MRL, Fonseca MEF, Oliveira LHS. 1994. Prevalence of human papillomavirus dna in female cervical lesions from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 89:575-580.
9. Cavalcanti SMB, Zardo LG, Passos MRL, Oliveira LHS. 2000. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil. J Infect 40:80-87. (Pubitemid 30157779)
10. Cerqueira DM, Camara GNL, Cruz MR, Silva EO, Brígido MM, Carvalho LGS, Martins CRF. 2003. Variants of human papillomavirus types 53,58 and 66 identified in Central Brazil. Virus Genes 26:83-87. (Pubitemid 36363313)
11. Chan PKS, Li W-H, Chan MYM, Ma W-L, Cheung JLK, Cheng AF. 1999.High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 59:232-238. (Pubitemid 29407287)
12. Chan PKS, Lam C-W, Cheung T-H, Li WW-H, Lo KWK, Chan MYM, Cheung JLK, Cheng AF. 2002. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 94:1249-1253. (Pubitemid 34993876)
13. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J. 2000. Sexual behavior and smoking as determinants of cervical HPVinfection and NIC3 among those infected: A case-control study nested within the Manchester cohort. Br J Cancer 88:1565-1572.
14. Deluca GD, Lucero RH, de Civetta M. 2004. Human papillomavirus genotypes inwomen with cervical cytological abnormalities from an area with high incidence of cervical cancer. Rev Inst Med Trop Sao Paulo 46:9-12. (Pubitemid 38337720)
15. Fife KH, Cramer HM, Schroeder JM, Brown DR. 2001. Detection of multiple human papillomavirus type in the lower genital tract correlates with cervical dysplasia. J Med Virol 64:550-559. (Pubitemid 32613745)
16. González-Bosquet E, Esteva C, Muñoz-Almagro C, Ferrer P, Pérez M, Lailla JM. 2008. Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3). Gynecol Oncol 111:9-18.
17. González-Losa M, Rosado-Lopes I, Valdez-González N, Puerto-Solís M. 2004.High prevalence of human papillomavirus type 58 inMexican colposcopy patients. J Clin Virol 29:202-205.
18. Gravitt PE, Pwyton CL, Apple RJ, Wheeler CM. 1998. Genotyping of 27 human papillomavirus types by using l1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 36:3020-3027. (Pubitemid 28429431)
19. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169: 235-240. (Pubitemid 24045578)
20. Iftner T, Villa LL. 2003. Human Papillomavirus Technologies. J Natl Cancer Inst Monogr 31:80-88.
21. INCA-Instituto Nacional do Câncer. Ministério da Saú de. 2008. http://www.inca.gov.br.
22. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. 2003. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol 71:265-273.
23. Klug SJ, Hukelmann M, Hollwitz B, Duzenli N, Schopp B, Petry KU, Iftner T. 2007.Prevalence ofhumanpapillomavirus types in women screened by cytology in Germany. J Med Virol 79:616-625. (Pubitemid 46564361)
24. Lai HC, Sun CA, Yu MH, Chen HJ, Liu HS, Chu TY. 1999. Favorable clinical outcome of cervical cancers infected with human papillomavirus type 58 and related types. Int J Cancer Suppl 84:553-557.
25. Levi JE, Kleter B, Quint WGV, Fink MCS, Canto CLM, Matsubara R, Linhares I, Segurado A, Vanderborght B, Neto JE, Doorn LJ. 2002. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunode- ficiency virus-infected women in Brazil. J Clin Microbiol 40:3341-3345. (Pubitemid 34977451)
26. LiawKL,Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, Scott DR, Sherman ME, Kurman RJ, Glass AG, Anderson SM, Schiffman M. 2001. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183:8-15. (Pubitemid 32043036)
27. Lin H, Ma YY, Moh JS, Ou YC, Shen SY, Changchien CC. 2006. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 101:40-45. (Pubitemid 43303557)
28. Manos MM. 2001. HPV testing for clarifying borderline cervical smear results. BMJ 322:878-879.
29. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
30. Matos A, Moutinho J, Pinto D, Medeiros R. 2005. The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. Eur JCancer Prev 14:485-491. Matsukura T, Sugase M. 1990. Molecular cloning of a novel human papillomavirus (type 58) from an invasive cervical carcinoma. Virology 177:833-836. (Pubitemid 41433648)
31. Muñ oz N. 2000. Human papillomavirus and cancer: The epidemiological evidence. J Clinical Virol 19:1-5.
32. Muñ oz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Ascunce N. 1992. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain. Int J Cancer Suppl 52:743-749.
33. Muñ oz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
34. Rabelo-Santos SH, Zeferino L, Villa LL, Sobrinho JP, Amaral RG, Magalhães AV. 2003. Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiânia, Brazil Mem Inst Oswaldo Cruz. 98:181-184.
35. Rombaldi R, Serafini EP, Villa LL, Vanni AC, Baréa F, Frassini R, Xavier M, Paesi S. 2006. Infection with human papillomaviruses of sexual partners ofwomen having cervical intraepithelial neoplasia. Braz J Med Biol Res 39:177-187.
36. Rousseau M, Franco EL, Villa LL, Sobrinho JP, Termini L, Prado JM, Rohan TE. 2000. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 9:469-476. (Pubitemid 30313889)
37. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. 2003. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 12:1029-1037. (Pubitemid 37310259)
38. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R,Horn GT, Mullis KB, Erlich HA. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KJ,KimHH,Park UD, Cha HS, Park S, TouzeA,Muñ oz N, Snijders PJ, Coursaget P, Franceschi S. 2003. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer Suppl 103:413-421. (Pubitemid 18084310)
39. Stanczuk GA, Kay P, Sibanda E, Allan B, Chirara M, Tswana SA, Bergstrom S, Williamson AL. 2003. Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix. Acta Obstet Gynecol Scand 82:762-766. (Pubitemid 36898056)
40. Stanley M. 2008. Human papillomavirus vaccines versus cervical cancer screening. Clin Oncol (R Coll Radiol) 20:388-394. Epub 2008 Jun 5.
41. Tonon SA, Picconi MA, Zinovich JB, Nardari W, Mampaey M, Bada DLF, Galuppo JA, Alonio LV, Teyssie AR. 2004. Human papillomavirus cervical infection in Guarani Indians from the rainforest of Misiones, Argentina. J Infect Dis 8:13-19. (Pubitemid 38094899)
42. Touzé A, Sanjosé S, Coursaget P, Almirall MR, Palacio V, Meijer CJLM, Kornegay J, Bosch FX. 2001. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol 39:4344-4348. (Pubitemid 33117121)
43. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2006. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15:1274-1280. (Pubitemid 44125281)
44. Veras VS, Cerqueira DM, Martins CRF. 2005. L1 Sequence of a new human papillomavirus type-58 variant associated with cervical intraepithelial neoplasia. Braz J Med Biol Res 38:1-4. (Pubitemid 40277932)
45. Villiers E-M, FauquetC,Broker TR, Bernard H-U, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
46. zur Hausen H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.